Published in Cell on January 31, 2013
A cannabinoid link between mitochondria and memory. Nature (2016) 2.04
Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci (2014) 1.66
Glycolytic Enzymes Localize to Synapses under Energy Stress to Support Synaptic Function. Neuron (2016) 1.65
Axonal transport: cargo-specific mechanisms of motility and regulation. Neuron (2014) 1.55
Axon-soma communication in neuronal injury. Nat Rev Neurosci (2013) 1.31
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc (2014) 1.27
Mitochondria coordinate sites of axon branching through localized intra-axonal protein synthesis. Cell Rep (2013) 1.23
Glucose regulates mitochondrial motility via Milton modification by O-GlcNAc transferase. Cell (2014) 1.21
Microtubules and their role in cellular stress in cancer. Front Oncol (2014) 1.15
Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons. J Neurosci (2014) 1.11
Cytoplasmic dynein heavy chain: the servant of many masters. Trends Neurosci (2013) 1.09
Regulation of mitochondrial transport in neurons. Exp Cell Res (2015) 1.06
Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies. J Neurosci (2013) 1.02
Changing appetites: the adaptive advantages of fuel choice. Trends Cell Biol (2013) 1.00
Characterization of Alternaria infectoria extracellular vesicles. Med Mycol (2013) 0.99
The role of mitochondrially derived ATP in synaptic vesicle recycling. J Biol Chem (2015) 0.98
Rabies Virus Hijacks and accelerates the p75NTR retrograde axonal transport machinery. PLoS Pathog (2014) 0.97
Endothelial cell metabolism: parallels and divergences with cancer cell metabolism. Cancer Metab (2014) 0.92
PGC-1α, mitochondrial dysfunction, and Huntington's disease. Free Radic Biol Med (2013) 0.92
Subunit composition of the human cytoplasmic dynein-2 complex. J Cell Sci (2014) 0.91
Altered brain energetics induces mitochondrial fission arrest in Alzheimer's Disease. Sci Rep (2016) 0.91
Underestimation of the pentose-phosphate pathway in intact primary neurons as revealed by metabolic flux analysis. J Cereb Blood Flow Metab (2013) 0.88
Metabolism regulates the spontaneous firing of substantia nigra pars reticulata neurons via KATP and nonselective cation channels. J Neurosci (2014) 0.87
Axonal transport declines with age in two distinct phases separated by a period of relative stability. Neurobiol Aging (2014) 0.87
Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits. J Neurosci (2014) 0.87
The intricate relationship between microtubules and their associated motor proteins during axon growth and maintenance. Neural Dev (2013) 0.86
Huntingtin's function in axonal transport is conserved in Drosophila melanogaster. PLoS One (2013) 0.85
A PIK3C3-ankyrin-B-dynactin pathway promotes axonal growth and multiorganelle transport. J Cell Biol (2014) 0.85
An exploration of how the thermodynamic efficiency of bioenergetic membrane systems varies with c-subunit stoichiometry of F₁F₀ ATP synthases. J Bioenerg Biomembr (2014) 0.84
Evaluation of housekeeping genes as references for quantitative real-time PCR analysis of gene expression in the murrel Channa striatus under high-temperature stress. Fish Physiol Biochem (2015) 0.84
Axonal transport plays a crucial role in mediating the axon-protective effects of NmNAT. Neurobiol Dis (2014) 0.84
Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease. PLoS One (2013) 0.84
Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia. Clin Proteomics (2014) 0.84
Compartment-Specific Regulation of Autophagy in Primary Neurons. J Neurosci (2016) 0.83
Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain? Mol Cell Proteomics (2015) 0.82
Proteolipid protein-deficient myelin promotes axonal mitochondrial dysfunction via altered metabolic coupling. J Cell Biol (2016) 0.81
Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis. BMC Genomics (2014) 0.81
An EMMPRIN-γ-catenin-Nm23 complex drives ATP production and actomyosin contractility at endothelial junctions. J Cell Sci (2014) 0.81
Single-cell imaging tools for brain energy metabolism: a review. Neurophotonics (2014) 0.81
Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction. PLoS One (2013) 0.81
Analysis of Signaling Endosome Composition and Dynamics Using SILAC in Embryonic Stem Cell-Derived Neurons. Mol Cell Proteomics (2015) 0.80
Prospects for neuroprotective therapies in prodromal Huntington's disease. Mov Disord (2014) 0.80
Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation. Arterioscler Thromb Vasc Biol (2017) 0.79
Imaging changes in the cytosolic ATP-to-ADP ratio. Methods Enzymol (2014) 0.79
A huntingtin-mediated fast stress response halting endosomal trafficking is defective in Huntington's disease. Hum Mol Genet (2014) 0.79
Tumor protein Tctp regulates axon development in the embryonic visual system. Development (2016) 0.79
Huntingtin differentially regulates the axonal transport of a sub-set of Rab-containing vesicles in vivo. Hum Mol Genet (2015) 0.78
Separation of Binding Protein of Celangulin V from the Midgut of Mythimna separata Walker by Affinity Chromatography. Toxins (Basel) (2015) 0.78
Bioenergetics and redox adaptations of astrocytes to neuronal activity. J Neurochem (2016) 0.78
Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models. Sci Rep (2016) 0.77
Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons. Neural Plast (2016) 0.77
Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? Neurobiol Dis (2017) 0.77
Axonal and dendritic localization of mRNAs for glycogen-metabolizing enzymes in cultured rodent neurons. BMC Neurosci (2014) 0.77
Beyond glycolysis: GAPDHs are multi-functional enzymes involved in regulation of ROS, autophagy, and plant immune responses. PLoS Genet (2015) 0.77
Glycolysis selectively shapes the presynaptic action potential waveform. J Neurophysiol (2016) 0.77
Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes. Int J Nanomedicine (2016) 0.76
Huntingtin acts non cell-autonomously on hippocampal neurogenesis and controls anxiety-related behaviors in adult mouse. PLoS One (2013) 0.76
Acute effect of lactic acid on tumor-endothelial cell metabolic coupling in the tumor microenvironment. Oncol Lett (2016) 0.76
Cell biology: Alternative energy for neuronal motors. Nature (2013) 0.76
Cell biology of the neuron: fuelling transport. Nat Rev Neurosci (2013) 0.76
In vivo imaging of axonal transport in murine motor and sensory neurons. J Neurosci Methods (2015) 0.76
Augmentation of glycolytic metabolism by meclizine is indispensable for protection of dorsal root ganglion neurons from hypoxia-induced mitochondrial compromise. Free Radic Biol Med (2016) 0.76
Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy. PLoS Genet (2017) 0.76
Local translation in neuronal compartments: how local is local? EMBO Rep (2017) 0.75
Drive the Car(go)s-New Modalities to Control Cargo Trafficking in Live Cells. Front Mol Neurosci (2017) 0.75
Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport. Nat Commun (2016) 0.75
The effects of endogenous non-peptide molecule isatin and hydrogen peroxide on proteomic profiling of rat brain amyloid-β binding proteins: relevance to Alzheimer's disease? Int J Mol Sci (2014) 0.75
Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma. Front Neurosci (2017) 0.75
Spatial and temporal characteristics of normal and perturbed vesicle transport. PLoS One (2014) 0.75
Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics. Mar Drugs (2016) 0.75
Imaging Adenosine Triphosphate (ATP). Biol Bull (2016) 0.75
Identification of glyceraldehyde 3-phosphate dehydrogenase sequence and expression profiles in tree shrew (Tupaia belangeri). PLoS One (2014) 0.75
The advantage of channeling nucleotides for very processive functions. F1000Res (2017) 0.75
Candidate Reference Genes Selection and Application for RT-qPCR Analysis in Kenaf with Cytoplasmic Male Sterility Background. Front Plant Sci (2017) 0.75
Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage. Mol Neurobiol (2016) 0.75
Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing. Mol Ther Methods Clin Dev (2017) 0.75
Gpr158 mediates osteocalcin's regulation of cognition. J Exp Med (2017) 0.75
An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance. Int J Mol Sci (2017) 0.75
Neuronal SIRT1 (Silent Information Regulator 2 Homologue 1) Regulates Glycolysis and Mediates Resveratrol-Induced Ischemic Tolerance. Stroke (2017) 0.75
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med (2005) 6.58
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene (2002) 6.17
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med (2003) 5.96
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell (2004) 5.67
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med (2009) 5.05
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell (2009) 4.56
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell (2009) 4.47
Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J (2006) 4.43
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol (2007) 4.29
BoneJ: Free and extensible bone image analysis in ImageJ. Bone (2010) 3.91
Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci (2007) 3.79
Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell (2009) 3.71
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest (2008) 3.37
Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res (2009) 3.07
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene (2005) 3.05
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene (2002) 2.81
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat Biotechnol (2009) 2.76
LIS1, CLIP-170's key to the dynein/dynactin pathway. Mol Cell Biol (2002) 2.61
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell (2002) 2.56
Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron (2010) 2.54
A critical role for Stat3 signaling in immune tolerance. Immunity (2003) 2.41
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med (2010) 2.41
Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: a systematic review and meta-analysis. Stroke (2008) 2.33
Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol (2011) 2.24
TomoJ: tomography software for three-dimensional reconstruction in transmission electron microscopy. BMC Bioinformatics (2007) 2.13
Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J (2008) 2.03
Akt inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs (2010) 2.01
Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev (2005) 1.93
Role of Stat3 in regulating p53 expression and function. Mol Cell Biol (2005) 1.91
Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. J Clin Invest (2011) 1.79
Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation (2005) 1.79
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity. Mol Cancer Ther (2004) 1.70
Structure of a 14-3-3 coordinated hexamer of the plant plasma membrane H+ -ATPase by combining X-ray crystallography and electron cryomicroscopy. Mol Cell (2007) 1.67
S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell (2012) 1.64
Procentriole assembly revealed by cryo-electron tomography. EMBO J (2010) 1.64
Antitumor activity of targeting SRC kinases in endothelial and myeloid cell compartments of the tumor microenvironment. Clin Cancer Res (2010) 1.64
PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility. Nucleic Acids Res (2008) 1.61
The Fabrication of Nano-Particles in Aqueous Solution From Oxyfluoride Glass Ceramics by Thermal Induction and Corrosion Treatment. Nanoscale Res Lett (2008) 1.59
Nanodissection and high-resolution imaging of the Rhodopseudomonas viridis photosynthetic core complex in native membranes by AFM. Atomic force microscopy. Proc Natl Acad Sci U S A (2003) 1.56
Role of Stat3 in suppressing anti-tumor immunity. Curr Opin Immunol (2008) 1.52
Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice. J Hepatol (2012) 1.51
Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. Cancer Res (2009) 1.46
IL-17 enhances tumor development in carcinogen-induced skin cancer. Cancer Res (2010) 1.45
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest (2006) 1.44
Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells. Mol Cancer Res (2008) 1.43
Electron tomography of early melanosomes: implications for melanogenesis and the generation of fibrillar amyloid sheets. Proc Natl Acad Sci U S A (2008) 1.40
Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr Opin Neurol (2008) 1.40
Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene (2002) 1.38
Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways. Mol Cancer Res (2010) 1.35
Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects. Cancer Res (2010) 1.34
Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects. J Immunol (2005) 1.34
STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma. Cancer Res (2011) 1.30
Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet (2008) 1.28
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo. Blood (2013) 1.27
Akt is altered in an animal model of Huntington's disease and in patients. Eur J Neurosci (2005) 1.27
Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma. Cancer Res (2013) 1.26
Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci U S A (2012) 1.26
The C-terminal domain of Escherichia coli Hfq increases the stability of the hexamer. Eur J Biochem (2004) 1.25
Stat3 as a potential target for cancer immunotherapy. J Immunother (2007) 1.24
Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480. Cancer Res (2011) 1.23
L-arginine improves dystrophic phenotype in mdx mice. Neurobiol Dis (2005) 1.23
Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. Glia (2009) 1.21
Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis. J Mol Biol (2002) 1.20
A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment. PLoS One (2012) 1.20
Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J Neurosci (2007) 1.20
STAT3: a target to enhance antitumor immune response. Curr Top Microbiol Immunol (2011) 1.18
Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells. Cancer Res (2010) 1.18
Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses. J Biol Chem (2011) 1.18
Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J Biol Chem (2003) 1.17
Retracted Molecular cloning and characterization of the human AKT1 promoter uncovers its up-regulation by the Src/Stat3 pathway. J Biol Chem (2005) 1.17
Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J Neurosci (2006) 1.16
Visualization of proteins in intact cells with a clonable tag for electron microscopy. J Struct Biol (2008) 1.15
The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur J Neurosci (2004) 1.15
Self-assembling SAS-6 multimer is a core centriole building block. J Biol Chem (2010) 1.14
Activation of the plant plasma membrane H+-ATPase by phosphorylation and binding of 14-3-3 proteins converts a dimer into a hexamer. Proc Natl Acad Sci U S A (2005) 1.14
Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. Cancer Res (2013) 1.13
Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J (2011) 1.12
iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma. J Proteome Res (2011) 1.11
Activated stat-3 in melanoma. Cancer Control (2008) 1.11
CCAAT/enhancer-binding proteins beta and delta mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1 beta. J Biol Chem (2002) 1.10
Elongator - an emerging role in neurological disorders. Trends Mol Med (2009) 1.10
A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci (2012) 1.09
COHCAP: an integrative genomic pipeline for single-nucleotide resolution DNA methylation analysis. Nucleic Acids Res (2013) 1.08
B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma. J Invest Dermatol (2013) 1.07
Bloom's syndrome and PICH helicases cooperate with topoisomerase IIα in centromere disjunction before anaphase. PLoS One (2012) 1.06
In situ growth of a ZnO nanowire network within a TiO(2) nanoparticle film for enhanced dye-sensitized solar cell performance. Adv Mater (2012) 1.06
Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Proc Natl Acad Sci U S A (2003) 1.05
Three-dimensional structures of fibrillar Sm proteins: Hfq and other Sm-like proteins. J Mol Biol (2005) 1.05
Early alterations of brain cellular energy homeostasis in Huntington disease models. J Biol Chem (2011) 1.05
Tissue plasminogen activator prevents white matter damage following stroke. J Exp Med (2011) 1.03
S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. Blood (2012) 1.02